Positive patient identification refers to a combination of hardware and software solutions designed for identifying a patient’s details so as to ensure correct medication is provided to the same.
This report contains market size and forecasts of Positive Patient Identification (PPID) in Global, including the following market information:
Global Positive Patient Identification (PPID) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Positive Patient Identification (PPID) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Scanning Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Positive Patient Identification (PPID) include Imprivata, Inc., RightPatient, Inc., General Data Company, Inc., GBS Corporation, MSoft eSolutions Ltd., PatientWorks Corporation, SATO Holdings Corporation, Zebra Technologies and RMS Omega Technologies Group, Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Positive Patient Identification (PPID) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Positive Patient Identification (PPID) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Positive Patient Identification (PPID) Market Segment Percentages, by Type, 2021 (%)
Scanning Devices
Software
Services
Global Positive Patient Identification (PPID) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Positive Patient Identification (PPID) Market Segment Percentages, by Application, 2021 (%)
Web Based
Cloud Based
Global Positive Patient Identification (PPID) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Positive Patient Identification (PPID) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Positive Patient Identification (PPID) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Positive Patient Identification (PPID) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Imprivata, Inc.
RightPatient, Inc.
General Data Company, Inc.
GBS Corporation
MSoft eSolutions Ltd.
PatientWorks Corporation
SATO Holdings Corporation
Zebra Technologies
RMS Omega Technologies Group, Inc.